43 results
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Aug 22
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
9:16am
, net
Intangible assets, net
API purchase commitment
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts … related to Vivus Settlement
Noncash increase in promissory note related to Vivus settlement
Noncash decrease in API purchase commitment
The accompanying Notes are an integral part of the Consolidated Financial Statements.
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Nov 22
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
8:30am
current assets
Total current assets
Fixed assets, net
Intangible assets, net
API purchase commitment
Other assets
Total assets
Liabilities … purchases related to Vivus Settlement
Noncash increase in promissory note related to Vivus settlement
Noncash decrease in API purchase commitment
Noncash
10-Q
2021 Q1
PTPI
Petros Pharmaceuticals Inc
14 May 21
Quarterly report
4:31pm
commitment
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Current portion of senior debt, net
Accounts payable
Accrued … purchase commitment asset (see Note 14)
Other prepaid expenses
Other current assets
Total prepaid expenses and other current assets
Prepaid samples, which
8-K
EX-10.3
towcyqtd6 5r
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
zk438p
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
8-K
EX-3.2
j7r318sot
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-99.1
adw4udghdviomixb0d
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
PRE 14A
ap2fl zcux88a
30 Sep 22
Preliminary proxy
4:45pm
424B3
7iedhj2ej matw
14 Jan 22
Prospectus supplement
5:18pm
DEF 14A
79gydgx8zx6fpxs0e6
22 Nov 21
Definitive proxy
4:37pm
10-K
EX-10.1
w5kprmzyv94z
31 Mar 21
Annual report
4:30pm
10-K
ip4th1u49mjodng
31 Mar 21
Annual report
4:30pm